John P. Hamill

APRE

John P. Hamill serves as officer: SrVP/CFO/Prin Fin & Acct Ofcr at Aprea Therapeutics, Inc. (APRE). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

6 trades

$24.6K

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$24.6K

Companies Traded

APRE

Active Period

Mar 2024 – Feb 2026

6 total trades

Most Recent

Buy APRE

Feb 2, 2026 · $5.1K

John P. Hamill's Insider Trading at Aprea Therapeutics, Inc. (APRE)

Buys

6 · $24.6K

Sells

0 · $0.00

Total Shares Bought

17,910

Total Shares Sold

APRE Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Feb 2, 2026↗	Buy	5,700	$0.89	$5.1K	33,433
Jan 30, 2026↗	Buy	5,700	$0.89	$5.1K	0
Dec 10, 2025↗	Buy	5,000	$1.17	$5.8K	0
Oct 11, 2024↗	Buy	50	$2.46	$123.19	0
Oct 10, 2024↗	Buy	450	$2.61	$1.2K	0
Mar 13, 2024↗	Buy	1,010	$7.29	$7.4K	0

Related Insiders

Oren Gilad

President/CEO

APREBuy · Jan 30, 2026

Marc Duey

Director

APREBuy · Dec 10, 2025

Explore More Insider Trading Data

APRE Insider Trading Activity

View all insider trades at Aprea Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity